Patent · US Active

NK1 antagonists

US8796299B2 · kind B2 · utility

9Cited by

15References

15Claims

0Family size

Assignee

OPKO Health, Inc. · US

Inventors

Sunil Paliwal · Manalapan, US
Gregory A. Reichard · Lovettsville, US
Cheng Wang · Fort Washington, US
Dong Xiao · Hackettstown, US
Hon-Chung Tsui · East Brunswick Township, US
Neng-Yang Shih · Lexington, US
Juan D. Arredondo · Montclair, US
Michelle Laci Wrobleski · Whitehouse Station, US
Anandan Palani · Bound Brook, US

Key dates

Filing date	Sep 24, 2012
Grant date	Aug 5, 2014
Priority date	—
Expiry date	Sep 24, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A NK1 antagonist having the formula (I),

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.